Insiders · Profile

Nabulsi Azmi

Chief Operating Officer at Phathom Pharmaceuticals. Filing since 4 Jan 2020. CIK 0001791412

Company
Date
Role
Action
Shares
Amount
Of holding
21 Jan 2025
Chief Operating Officer
Sold at will
7,886
$51.96K
3.3%
19 Dec 2024
Chief Operating Officer
Sold at will
1,118
$8.94K
0.5%
15 Jul 2024
Chief Operating Officer
Sold at will
10,901
$127.76K
4.3%
11 Apr 2023
Chief Operating Officer
Bought
10,000
$82.60K
11.2%
16 May 2022
Chief Operating Officer
Bought
20,000
$163.29K
2.6%
4 May 2021
Chief Operating Officer
Sold, plan not stated
4,457
$164.30K
0.6%
3 May 2021
Chief Operating Officer
Sold, plan not stated
10,043
$384.35K
1.3%
5 Apr 2021
Chief Operating Officer
Sold, plan not stated
9,353
$337.73K
1.2%
1 Apr 2021
Chief Operating Officer
Sold, plan not stated
5,147
$193.37K
0.6%
2 Mar 2021
Chief Operating Officer
Sold, plan not stated
9,127
$418.93K
1.1%
1 Mar 2021
Chief Operating Officer
Sold, plan not stated
5,373
$246.36K
0.7%
2 Feb 2021
Chief Operating Officer
Sold, plan not stated
9,084
$372.16K
1.1%
1 Feb 2021
Chief Operating Officer
Sold, plan not stated
5,416
$206.29K
0.7%
2 Dec 2020
Chief Operating Officer
Sold, plan not stated
7,302
$330.51K
0.9%
1 Dec 2020
Chief Operating Officer
Sold, plan not stated
7,198
$318.18K
0.8%
2 Nov 2020
Chief Operating Officer
Sold, plan not stated
14,500
$534.03K
1.7%
5 Jan 2020
Chief Operating Officer
Sold, plan not stated
1,854
$62.61K
0.2%
4 Jan 2020
Chief Operating Officer
Sold, plan not stated
12,646
$424.67K
1.5%
18 decisions on file.